Pharmaxis Sells Bronchitol Russian Distribution Rights for A$2m with Annual A$1m Cost Savings
14th
Apr 21
Release Date: 14/04/2021 9:25am
Highlights:
- Pharmaxis sells distribution rights for Bronchitol in Russia effective May 1st 2021
- Pharmaxis to receive a €1.25 million (~A$2m) distributor appointment fee
- Annual cost savings of approximately A$1m realised from transfer of commercial and product responsibilities
Categories: News and Media